Developing Anticoagulation Self-Report Measure in Adults

Not yet recruitingOBSERVATIONAL
Enrollment

305

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

October 31, 2026

Conditions
Adults Undergoing Oral Anticoagulation Therapy
Interventions
OTHER

Participation in an web-based survey

Patients who agree to participate will access a web-based survey (SurveyMonkey) via social media, mobile messages, or emails. The invitation will provide study details, eligibility criteria, and tasks. Patients will confirm inclusion/exclusion criteria upon access, and those ineligible will opt out. Data collection will take approximately 10 minutes per patient. Collected data will be sent to an electronic data collector and saved as an eCRF file in REDCap. The study will conduct two cross-sectional data collection rounds using web surveys to ensure anonymity. Convenience sampling will target anticoagulated patient associations' webpages and social media (e.g., Feder-AIPA, AICCA). In the second round, participants will be informed not to resubmit if they have already completed the survey to avoid overlapping responses.

Trial Locations (1)

20097

IRCCS Policlinico San Donato, San Donato Milanese

All Listed Sponsors
lead

IRCCS Policlinico S. Donato

OTHER

NCT05973240 - Developing Anticoagulation Self-Report Measure in Adults | Biotech Hunter | Biotech Hunter